Home LiteratureArticle Details
PMID: 20644535 Published · ppublish English Journal Article Research Support, American Recovery and Reinvestment Act Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Epigenetic memory in induced pluripotent stem cells.

Nature ·Vol. 467 ·No. 7313 ·2010-09-16 ·Pages 285-90

Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ

Abstract

Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an 'epigenetic memory' of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer is more effective at establishing the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.

MeSH Terms
Animals Cell Differentiation/genetics Cell Lineage/genetics Cellular Reprogramming/genetics DNA Methylation/genetics Embryonic Stem Cells/cytology,metabolism Epigenesis, Genetic Genome/genetics Hematopoietic Stem Cells/cytology,metabolism Induced Pluripotent Stem Cells/cytology,metabolism Mice Mice, Inbred C57BL Mice, Inbred CBA Nuclear Transfer Techniques Transcription Factors/genetics,metabolism
Chemicals
Transcription Factors
Authors & Affiliations
28 authors, click to expand affiliations / ORCID
Kim K
Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Doi A
Wen B
Ng K
Zhao R
Cahan P
Kim J
Aryee M J
Ji H
Ehrlich L I R
Yabuuchi A
Takeuchi A
Cunniff K C
Hongguang H
McKinney-Freeman S
Naveiras O
Yoon T J
Irizarry R A
Jung N
Seita J
Hanna J
Murakami P
Jaenisch R
Weissleder R
Orkin S H
Weissman I L
Feinberg A P
Daley G Q
References (52)
52 references, click to expand
  1. Analysis of strain and regional variation in gene expression in mouse brain.
    Genome Biol. 2001;2(10):RESEARCH0042 PMID: 11597334
  2. Variation in the safety of induced pluripotent stem cell lines.
    Nat Biotechnol. 2009 Aug;27(8):743-5 PMID: 19590502
  3. Osteogenic differentiation of mouse embryonic stem cells: differential gene expression analysis by cDNA microarray and purification of osteoblasts by cadherin-11 magnetically activated cell sorting.
    Tissue Eng. 2004 May-Jun;10(5-6):796-806 PMID: 15265297
  4. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation.
    Proc Natl Acad Sci U S A. 2001 May 22;98(11):6209-14 PMID: 11331774
  5. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.
    Nat Biotechnol. 2009 Nov;27(11):1033-7 PMID: 19826408
  6. Generation of pluripotent stem cells from adult mouse liver and stomach cells.
    Science. 2008 Aug 1;321(5889):699-702 PMID: 18276851
  7. A high-efficiency system for the generation and study of human induced pluripotent stem cells.
    Cell Stem Cell. 2008 Sep 11;3(3):340-5 PMID: 18786420
  8. Nuclear reprogramming in cells.
    Science. 2008 Dec 19;322(5909):1811-5 PMID: 19095934
  9. Transgenic mice with defined combinations of drug-inducible reprogramming factors.
    Nat Biotechnol. 2009 Feb;27(2):169-71 PMID: 19151700
  10. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
    Cell. 2008 Apr 18;133(2):250-64 PMID: 18423197
  11. Gene silencing in mammalian cells and the spread of DNA methylation.
    Oncogene. 2002 Aug 12;21(35):5388-93 PMID: 12154401
  12. Marked differences in differentiation propensity among human embryonic stem cell lines.
    Nat Biotechnol. 2008 Mar;26(3):313-5 PMID: 18278034
  13. DNA methylation models histone acetylation.
    Nature. 1998 Aug 27;394(6696):842 PMID: 9732866
  14. iPS cells produce viable mice through tetraploid complementation.
    Nature. 2009 Sep 3;461(7260):86-90 PMID: 19672241
  15. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.
    Cell Stem Cell. 2009 Jul 2;5(1):111-23 PMID: 19570518
  16. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway.
    Cell Stem Cell. 2008 Jan 10;2(1):72-82 PMID: 18371423
  17. Generation of germline-competent induced pluripotent stem cells.
    Nature. 2007 Jul 19;448(7151):313-7 PMID: 17554338
  18. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.
    Nature. 2009 Aug 27;460(7259):1149-53 PMID: 19668189
  19. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.
    Nat Biotechnol. 2008 Aug;26(8):916-24 PMID: 18594521
  20. Comprehensive high-throughput arrays for relative methylation (CHARM).
    Genome Res. 2008 May;18(5):780-90 PMID: 18316654
  21. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells.
    Genes Dev. 2009 Dec 15;23(24):2824-38 PMID: 20008934
  22. Oct4-induced pluripotency in adult neural stem cells.
    Cell. 2009 Feb 6;136(3):411-9 PMID: 19203577
  23. Dynamic reprogramming of DNA methylation in the early mouse embryo.
    Dev Biol. 2002 Jan 1;241(1):172-82 PMID: 11784103
  24. Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus.
    Stem Cells. 2006 Sep;24(9):2007-13 PMID: 16709876
  25. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Cell. 2006 Aug 25;126(4):663-76 PMID: 16904174
  26. An extended transcriptional network for pluripotency of embryonic stem cells.
    Cell. 2008 Mar 21;132(6):1049-61 PMID: 18358816
  27. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells.
    Nature. 2010 May 13;465(7295):175-81 PMID: 20418860
  28. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.
    Nat Genet. 2009 Sep;41(9):968-76 PMID: 19668214
  29. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.
    Nat Genet. 2009 Feb;41(2):178-186 PMID: 19151715
  30. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
    Nature. 2007 Jul 19;448(7151):318-24 PMID: 17554336
  31. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable.
    Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):933-8 PMID: 16418286
  32. Generation of induced pluripotent stem cells from human blood.
    Blood. 2009 May 28;113(22):5476-9 PMID: 19299331
  33. Variation in the protocadherin gamma A gene cluster.
    Genomics. 2003 Oct;82(4):433-40 PMID: 13679023
  34. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts.
    Nat Genet. 2009 Dec;41(12):1350-3 PMID: 19881528
  35. A bivalent chromatin structure marks key developmental genes in embryonic stem cells.
    Cell. 2006 Apr 21;125(2):315-26 PMID: 16630819
  36. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.
    Cell. 2009 Mar 6;136(5):964-77 PMID: 19269371
  37. 5-Azacytidine permits gene activation in a previously noninducible cell type.
    Cell. 1985 Feb;40(2):417-24 PMID: 2578323
  38. Direct cell reprogramming is a stochastic process amenable to acceleration.
    Nature. 2009 Dec 3;462(7273):595-601 PMID: 19898493
  39. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.
    Cell. 2002 Apr 5;109(1):29-37 PMID: 11955444
  40. A mouse model for beta-thalassemia.
    Cell. 1983 Oct;34(3):1043-52 PMID: 6313205
  41. Promotion of reprogramming to ground state pluripotency by signal inhibition.
    PLoS Biol. 2008 Oct 21;6(10):e253 PMID: 18942890
  42. A modification of alizarin red S technic for demonstrating bone formation.
    Stain Technol. 1948 Oct;23(4):209-18 PMID: 18884571
  43. Broader implications of defining standards for the pluripotency of iPSCs.
    Cell Stem Cell. 2009 Mar 6;4(3):200-1; author reply 202 PMID: 19265657
  44. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell.
    PLoS Biol. 2005 Sep;3(9):e283 PMID: 16086633
  45. The Ink4/Arf locus is a barrier for iPS cell reprogramming.
    Nature. 2009 Aug 27;460(7259):1136-9 PMID: 19668188
  46. Novel retroviral vectors to facilitate expression screens in mammalian cells.
    Nucleic Acids Res. 2002 Dec 15;30(24):e142 PMID: 12490733
  47. Dissecting direct reprogramming through integrative genomic analysis.
    Nature. 2008 Jul 3;454(7200):49-55 PMID: 18509334
  48. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells.
    Nat Biotechnol. 2009 Apr;27(4):361-8 PMID: 19329998
  49. Phenotype and hematopoietic potential of side population cells throughout embryonic development.
    Blood. 2003 Oct 1;102(7):2436-43 PMID: 12805065
  50. Differentiation of mouse embryonic stem cells and of human adult stem cells into adipocytes.
    Curr Protoc Cell Biol. 2007 Mar;Chapter 23:Unit 23.4 PMID: 18228505
  51. Study of stem cell function using microarray experiments.
    FEBS Lett. 2005 Mar 21;579(8):1795-801 PMID: 15763554
  52. HOXB4's road map to stem cell expansion.
    Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16952-7 PMID: 17940039
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2010-09-16
Pages
285-90
Language
English
Region
England
NLM ID
0410462
PMCID
PMC3150836
Subset
IM
Grants
NHLBI NIH HHS · HL099999 · United States
NIAID NIH HHS · R01AI047458 · United States
NIDDK NIH HHS · R01-DK70055 · United States
NIDDK NIH HHS · R01 DK059279 · United States
NIDDK NIH HHS · R01 DK070055 · United States
NCI NIH HHS · CA86065 · United States
NHLBI NIH HHS · K99 HL093212 · United States
NCI NIH HHS · R37CA054358 · United States
NIAID NIH HHS · R01AI047457 · United States
NHGRI NIH HHS · P50HG003233 · United States
NIAID NIH HHS · R01 AI047457 · United States
NIH HHS · DP1 OD000256-01 · United States
NIDDK NIH HHS · R01 DK059279-10 · United States
NCI NIH HHS · R01 CA086065 · United States
NIDDK NIH HHS · R01 DK059279-02 · United States
NCI NIH HHS · R37 CA054358 · United States
NHLBI NIH HHS · K99 HL093212-01 · United States
NIDDK NIH HHS · R01 DK070055-01 · United States
NHGRI NIH HHS · P50 HG003233 · United States
NIGMS NIH HHS · R01 GM083084-04 · United States
NHLBI NIH HHS · RC2-HL102815 · United States
Howard Hughes Medical Institute · United States
NHLBI NIH HHS · U01 HL099999 · United States
NHLBI NIH HHS · K99HL093212-01 · United States
NIGMS NIH HHS · R01 GM083084 · United States
NIAID NIH HHS · R01 AI047458 · United States
NIH HHS · DP1 OD000256 · United States
NHLBI NIH HHS · RC2 HL102815 · United States
NICHD NIH HHS · R37 HD045022 · United States
NHLBI NIH HHS · K99 HL093212-02 · United States
NHLBI NIH HHS · RC2 HL102815-01 · United States
NIDDK NIH HHS · R01-DK59279 · United States
Databases
GEO
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]